Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Hyperbaric Oxygen Therapy on Brain Function in Patients With Cognitive Decline After COVID-19 Infection.

NCT05715801 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Zhejiang Chinese Medical University as lead sponsor.

NCT NCT05715801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05715801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Hyperbaric Oxygen Therapy on Brain Function in Patients With Cognitive Decline After COVID-19 Infection.
Lead sponsor
The First Affiliated Hospital of Zhejiang Chinese Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
January 29, 2023
Completion date
January 31, 2024
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive decline, covid-19, sars cov 2 infection